Intimation regarding the Investor / Analyst Call scheduled to be held on Friday, September 11, 2026, 04:00 PM IST onwards, through Physical and Virtual Mode.

Novartis India Limited September 08, 2026 The Secretary, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Scrip Code: 500672 Subject: Intimation of Analyst / Institutional Investor Meeting under Regulation 30 of SEBI (LODR) Regulations, 2015. Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule III Part A Para A sub-para 15 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company shall convene an Analyst / Institutional Investor Meeting. The details are as below: - Date Friday, September 11, 2026, Event Investor / Analyst Call Time 04:00 pm IST on wards Location Mumbai Mode Virtual and Physical both Type of the meeting General Group Meeting Note: - The above schedule may undergo change due to exigencies on the part of investors/analysts/Company. Participants who wish to confirm their attendance for the Investor / Analyst Call are requested to write at investor.relations@nilpharma.co.in. This is to further inform you that the Company will refer only to publicly available information during the discussion at the meeting and no unpublished price sensitive information will be shared in the said meeting. The presentation shall be made available before the event on stock exchange i.e. BSE Limited and on the website of the Company at https://nilpharma.co.in/ You are requested to take the same on record. Thank you. For Novartis India Limited Chandni Maru Company Secretary and Compliance Officer A60291 Registered Office: Inspire BKC, 7th Floor, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra, India. CIN: L24200MH1947PLC006104 | Tel: +91 22 50243000 Email: investor.relations@nilpharma.co.in | Website: www.nilpharma.co.in